Publications

2026

Back to Top

Ultrasound-guided skeletal muscle biopsy technique permits measurement of structural, functional, cellular and biochemical properties.

Does Cachexia Matter for Glioblastoma Multiforme?

Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium.

Ultrasound-guided skeletal muscle biopsy technique permits measurement of structural, functional, cellular and biochemical properties.

2025

Back to Top

Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy.

Predicting medical prognosis in patients with glioblastoma during inpatient rehabilitation using bed mobility function.

Cancer Cachexia Rehabilitation in a Novel Outpatient Clinical Program.

Inpatient Rehabilitation Outcomes of Cancer Patients After Chimeric Antigen Receptor T-Cell Therapy.

Prehabilitation for muscle wasting in cancer: do definitions matter?

Six-Minute Walk Test Is Superior to Grip Strength as a Marker of Functional Recovery During Cancer Cachexia Rehabilitation.

Natural language processing algorithms identify wild-type isocitrate dehydrogenase gliomas in electronic health records.

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy.

Immunomodulatory role of the stem cell circadian clock in muscle repair.

Weight and Blood-Based Markers of Cachexia Predict Disability, Hospitalization and Worse Survival in Cancer Immunotherapy Patients.

Ablation of satellite cell-specific clock gene, Bmal1, alters force production, muscle damage, and repair following contractile-induced injury.

A Dynamic Time Warping Extension to Consensus Weight-Based Cachexia Criteria Improves Prediction of Cancer Patient Outcomes.

2024

Back to Top

Shifting the Curve: Mastery Learning to Teach Nerve Conduction Studies in Physical Medicine and Rehabilitation Residency.

Low-dose orthotopic cancer implantation permits measurement of longitudinal functional changes associated with cachexia.

Decreased Bed Mobility Function Is Associated With Postdischarge Mortality for Cancer Patients in Inpatient Rehabilitation.

Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy.

Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.

Immunomodulatory Role of the Stem Cell Circadian Clock in Muscle Repair.

Impact of cachexia on disease recurrence and survival outcomes in endometrial cancer patients.

2023

Back to Top

Gait speed is a biomarker of cancer-associated cachexia decline and recovery.

Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL.

2022

Back to Top

THE RELATIONSHIP BETWEEN CACHEXIA AND THE FUNCTIONAL PROGRESS OF PATIENTS WITH CANCER IN INPATIENT REHABILITATION.

Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.

A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer.

2021

Back to Top

2017

Back to Top

Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.

Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma.

Exploiting agonist biased signaling of chemokines to target cancer.

2015

Back to Top

Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling.

Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells.

2014

Back to Top

CXM: a new tool for mapping breast cancer risk in the tumor microenvironment.

Chemokines in colitis: microRNA control.

CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis.